Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dickson

Showing results (441-450 of 520) with videos related to

Pageof 52
Sort By:
International Archives of Allergy and Immunology|January 1, 1992
Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigensT Iwayama, P S Leung, M Rowley, et al.
JCO Oncology Practice|April 19, 2021
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case StudyStephen M Schleicher, Basit Chaudhry, Natalie R Dickson, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitisW R Kim, J J Poterucha, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?P A Davis, P Leung, M Manns, et al.
Health Technology Assessment (Winchester, England)|June 11, 2015
Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Health Technology Assessment (Winchester, England)|July 27, 2013
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancerS Wojtowicz-Praga, J Torri, M Johnson, et al.
Hepatology (Baltimore, Md.)|March 1, 1996
Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complexS Moteki, P S Leung, E R Dickson, et al.
Health Technology Assessment (Winchester, England)|December 11, 2008
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluationC McLeod, N Fleeman, J Kirkham, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosisR Eastell, E R Dickson, S F Hodgson, et al.
Pageof 52

Showing results (441-450 of 520) with videos related to

Sort By:
Pageof 52
International Archives of Allergy and Immunology|January 1, 1992
Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigensT Iwayama, P S Leung, M Rowley, et al.
JCO Oncology Practice|April 19, 2021
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case StudyStephen M Schleicher, Basit Chaudhry, Natalie R Dickson, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitisW R Kim, J J Poterucha, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?P A Davis, P Leung, M Manns, et al.
Health Technology Assessment (Winchester, England)|June 11, 2015
Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Health Technology Assessment (Winchester, England)|July 27, 2013
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancerS Wojtowicz-Praga, J Torri, M Johnson, et al.
Hepatology (Baltimore, Md.)|March 1, 1996
Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complexS Moteki, P S Leung, E R Dickson, et al.
Health Technology Assessment (Winchester, England)|December 11, 2008
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluationC McLeod, N Fleeman, J Kirkham, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosisR Eastell, E R Dickson, S F Hodgson, et al.
Pageof 52